Genmab A (GMAB) Non-Current Receivables (2023 - 2025)
Genmab A (GMAB) has disclosed Non-Current Receivables for 1 consecutive years, with $10.0 million as the latest value for Q4 2023.
- For the quarter ending Q4 2023, Non-Current Receivables changed N/A year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Dec 2023, changed N/A, and an annual FY2023 reading of $10.0 million, changed N/A over the prior year.
- Non-Current Receivables was $10.0 million for Q4 2023 at Genmab A.
- Across five years, Non-Current Receivables topped out at $10.0 million in Q4 2023 and bottomed at $10.0 million in Q4 2023.